Krajina: Izrael
Jazyk: hebrejčina
Zdroj: Ministry of Health
PLERIXAFOR 24 MG / 1.2 ML
SANOFI - AVENTIS ISRAEL LTD
L03AX16
SOLUTION FOR INJECTION
S.C
GENZYME CORPORATION, USA
PLERIXAFOR
Mozobil is indicated in combination with G-CSF to enhance mobilisation of haematopietic stem cells to the peripheral blood for collection and subsequent autologous transplantation in patients with lymphoma and multiple myeloma .
2010-02-01